OXYCONTIN, the SIGN LANGUAGE, and the BLAGOJEVICH DEAL
OXYCONTIN, THE SIGN LANGUAGE, AND THE BLAGOJEVICH DEAL – Today I will deal with three issues, (1) the issue of drug addiction, in particular the OxyContin problem, (2) I will present the first problems of our economic disaster (3) and finally I will make a comment on the 6-figure book deal former Illinois Governor Blagojevich, also known as Goldfinger signed. — When researching the background of the drug addiction of certain celebrities, I came across a New York Times article of May 2007 – to which I came through a link of a law firms website reporting that three former and at that time current executives of Purdue Pharma had pled guilty to criminal charges that they had misled the FDA and physicians by not disclosing that OxyContin is addictive. OxyContin is said to be causing a sense of euphoria as it changes the chemical make-up of the brain. It may be habit-forming and should not given to someone who has a history of drug abuse or addiction. There seems to be a question whether oxycodone-induced brain changes can ever be repaired. — One of the victims of the Purdue cover-up of the addictive nature of oxycontin apparently was Republican spokesman and policy-maker Rush Limbaugh who several years back admitted in his radio program that he was addicted. Apparently, his admission followed his prosecution for felony doctor shopping, as reported by Law.com in May 2006. Prosecutor Roy Black finally agreed to a plea bargain that spared Limbaugh jail time under the condition that he attended an 18 months drug treatment program …
Share via e-mail
Filed under: drug treatment programs in nyc
Inc. has halted development of an experimental drug to treat the devastating neurodegenerative disorder known as Lou Gehrig's disease, saying Thursday that it proved ineffective in a late-stage clinical trial. The decision deals a blow to an estimated …
Read more on Boston Globe
Hannon Releases 2011-12 Health Committee Legislative Report
Filed under: drug treatment programs in nyc
Landmark legislation enacting the state's “I-STOP” (Internet System for Tracking Over-Prescribing) Act includes a series of provisions to overhaul the way prescription drugs are distributed and tracked in New York State. … other measures to protect …
Read more on Patch.com
Dexpramipexole: Lou Gehrig's Disease Drug Fails In Trial
Filed under: drug treatment programs in nyc
"We share the disappointment of members of the ALS community, who had hoped that dexpramipexole would offer a meaningful new treatment option," Biogen Executive Vice President of Research and Development Douglas Williams said in a statement.
Read more on Huffington Post
Aethlon Medical seeks US FDA permission to initiate clinical feasibility study …
Filed under: drug treatment programs in nyc
The study would be conducted by the Renal Research Institute (RRI), which was established in 1997 as a partnership between Fresenius Medical Care (FMC) and Beth Israel Medical Center, New York City. The Aethlon Hemopurifier is a … In the treatment of …
Read more on pharmabiz.com